DD210269A5 - Verfahren zur herstellung von chinazolin-herzstimulantien - Google Patents
Verfahren zur herstellung von chinazolin-herzstimulantien Download PDFInfo
- Publication number
- DD210269A5 DD210269A5 DD83250918A DD25091883A DD210269A5 DD 210269 A5 DD210269 A5 DD 210269A5 DD 83250918 A DD83250918 A DD 83250918A DD 25091883 A DD25091883 A DD 25091883A DD 210269 A5 DD210269 A5 DD 210269A5
- Authority
- DD
- German Democratic Republic
- Prior art keywords
- formula
- compound
- dioxide
- oil
- added
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
- C07D213/30—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
- C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
- C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
- C07D285/15—Six-membered rings
- C07D285/16—Thiadiazines; Hydrogenated thiadiazines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Cardiology (AREA)
- Hospice & Palliative Care (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB8214206 | 1982-05-15 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DD210269A5 true DD210269A5 (de) | 1984-06-06 |
Family
ID=10530384
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DD83250918A DD210269A5 (de) | 1982-05-15 | 1983-05-13 | Verfahren zur herstellung von chinazolin-herzstimulantien |
| DD83259680A DD216018A5 (de) | 1982-05-15 | 1983-05-13 | Verfahren zur herstellung von chinazolin-herzstimulantien |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DD83259680A DD216018A5 (de) | 1982-05-15 | 1983-05-13 | Verfahren zur herstellung von chinazolin-herzstimulantien |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US4489075A (pt) |
| EP (1) | EP0094766B1 (pt) |
| JP (1) | JPS58208289A (pt) |
| KR (1) | KR840004747A (pt) |
| AU (1) | AU538171B2 (pt) |
| CA (1) | CA1195977A (pt) |
| DD (2) | DD210269A5 (pt) |
| DE (1) | DE3368631D1 (pt) |
| DK (1) | DK210183A (pt) |
| ES (3) | ES8407039A1 (pt) |
| FI (1) | FI831684L (pt) |
| GR (1) | GR77498B (pt) |
| IL (1) | IL68668A0 (pt) |
| IN (1) | IN160680B (pt) |
| NO (1) | NO831728L (pt) |
| NZ (1) | NZ204225A (pt) |
| PH (1) | PH18763A (pt) |
| PL (2) | PL241968A1 (pt) |
| PT (1) | PT76687B (pt) |
| SU (1) | SU1194257A3 (pt) |
| YU (1) | YU105083A (pt) |
| ZA (1) | ZA833422B (pt) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8320958D0 (en) * | 1983-08-03 | 1983-09-07 | Pfizer Ltd | Quinazoline cardiac stimulants |
| JPS61215389A (ja) * | 1985-03-20 | 1986-09-25 | Kyowa Hakko Kogyo Co Ltd | キナゾリン誘導体およびそれを含有する強心剤 |
| US5138062A (en) * | 1989-10-03 | 1992-08-11 | Philip Morris Incorporated | Nicotine analogs |
| AU658194B2 (en) * | 1991-03-28 | 1995-04-06 | Eisai Co. Ltd. | Heterocyclic-cyclic amine derivatives |
| PT3143019T (pt) * | 2014-05-15 | 2021-01-28 | Pfizer | Forma cristalina de 6-[(4r)-4-metil-1,2-dióxido-1,2,6- tiadiazinan-2-il]isoquinolina-1-carbonitrilo |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3971783A (en) * | 1973-03-07 | 1976-07-27 | Pfizer Inc. | 4-Aminoquinazoline derivatives as cardiac stimulants |
| GB1460389A (en) * | 1974-07-25 | 1977-01-06 | Pfizer Ltd | 4-substituted quinazoline cardiac stimulants |
| US4171363A (en) * | 1977-02-22 | 1979-10-16 | Bristol-Myers Company | 1,2,3-Thiadiazole process |
| CA1086735A (en) * | 1977-11-03 | 1980-09-30 | John C. Danilewicz | Piperidino-quinazolines |
-
1983
- 1983-04-27 US US06/489,271 patent/US4489075A/en not_active Expired - Fee Related
- 1983-05-05 DE DE8383302529T patent/DE3368631D1/de not_active Expired
- 1983-05-05 EP EP83302529A patent/EP0094766B1/en not_active Expired
- 1983-05-10 IN IN297/DEL/83A patent/IN160680B/en unknown
- 1983-05-11 ES ES522278A patent/ES8407039A1/es not_active Expired
- 1983-05-11 DK DK210183A patent/DK210183A/da not_active Application Discontinuation
- 1983-05-12 YU YU01050/83A patent/YU105083A/xx unknown
- 1983-05-12 IL IL68668A patent/IL68668A0/xx unknown
- 1983-05-13 NZ NZ204225A patent/NZ204225A/en unknown
- 1983-05-13 ZA ZA833422A patent/ZA833422B/xx unknown
- 1983-05-13 PT PT76687A patent/PT76687B/pt unknown
- 1983-05-13 DD DD83250918A patent/DD210269A5/de unknown
- 1983-05-13 DD DD83259680A patent/DD216018A5/de unknown
- 1983-05-13 AU AU14522/83A patent/AU538171B2/en not_active Ceased
- 1983-05-13 SU SU833597905A patent/SU1194257A3/ru active
- 1983-05-13 FI FI831684A patent/FI831684L/fi not_active Application Discontinuation
- 1983-05-13 CA CA000428080A patent/CA1195977A/en not_active Expired
- 1983-05-13 PH PH28901A patent/PH18763A/en unknown
- 1983-05-13 NO NO831728A patent/NO831728L/no unknown
- 1983-05-13 GR GR71346A patent/GR77498B/el unknown
- 1983-05-13 PL PL24196883A patent/PL241968A1/xx unknown
- 1983-05-13 PL PL24705483A patent/PL247054A1/xx unknown
- 1983-05-14 KR KR1019830002145A patent/KR840004747A/ko not_active Application Discontinuation
- 1983-05-16 JP JP58085660A patent/JPS58208289A/ja active Pending
- 1983-12-28 ES ES528482A patent/ES528482A0/es active Granted
- 1983-12-28 ES ES528481A patent/ES8504793A1/es not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| CA1195977A (en) | 1985-10-29 |
| ES528481A0 (es) | 1985-05-01 |
| AU1452283A (en) | 1983-11-17 |
| JPS58208289A (ja) | 1983-12-03 |
| EP0094766A2 (en) | 1983-11-23 |
| PT76687A (en) | 1983-06-01 |
| DK210183A (da) | 1983-11-16 |
| EP0094766B1 (en) | 1986-12-30 |
| KR840004747A (ko) | 1984-10-24 |
| ES8504794A1 (es) | 1985-05-01 |
| PL247054A1 (en) | 1985-03-26 |
| IN160680B (pt) | 1987-07-25 |
| NZ204225A (en) | 1985-12-13 |
| DE3368631D1 (de) | 1987-02-05 |
| DD216018A5 (de) | 1984-11-28 |
| US4489075A (en) | 1984-12-18 |
| EP0094766A3 (en) | 1984-12-12 |
| IL68668A0 (en) | 1983-09-30 |
| ES528482A0 (es) | 1985-05-01 |
| FI831684A0 (fi) | 1983-05-13 |
| ES522278A0 (es) | 1984-08-16 |
| SU1194257A3 (ru) | 1985-11-23 |
| DK210183D0 (da) | 1983-05-11 |
| PH18763A (en) | 1985-09-20 |
| AU538171B2 (en) | 1984-08-02 |
| PL241968A1 (en) | 1984-08-13 |
| YU105083A (en) | 1986-02-28 |
| GR77498B (pt) | 1984-09-24 |
| PT76687B (en) | 1986-03-27 |
| ES8407039A1 (es) | 1984-08-16 |
| ZA833422B (en) | 1984-02-29 |
| FI831684L (fi) | 1983-11-16 |
| NO831728L (no) | 1983-11-16 |
| ES8504793A1 (es) | 1985-05-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69935600T2 (de) | Dihydrobenzodioxincarbonsäureamid- und ketonderivate als 5-ht4-rezeptorantagonisten | |
| DE3047142C2 (de) | Basische 1,7,7-Trimethylbicyclo[2,2,1]heptyläther, Verfahren zur Herstellung derselben und diese enthaltende Arzneimittel | |
| DE2513916A1 (de) | Substituierte benzamide | |
| DD261787A5 (de) | Antiarrhythmisch wirksame phenylpiperazin-mittel | |
| DD202426A5 (de) | Verfahren zur herstellung von 1,2-diaminocyclobuten-3,4-dionen | |
| DD213920A5 (de) | Verfahren zur herstellung von dihydropyridinen | |
| DD262023A5 (de) | Verfahren zur herstellung von dihydropyridinen | |
| DD215544A5 (de) | Verfahren zur herstellung von dihydropyridinen | |
| DE2341965A1 (de) | N- eckige klammer auf 1-(omegaphenylalkyl)-piperidyl-4 eckige klammer zu -n-(alpha-pyridyl)-carbonsaeureamide, deren saeureadditionssalze, verfahren zu deren herstellung, sowie deren verwendung als arzneimittel | |
| DD202293A5 (de) | Verfahren zur herstellung von 2-guanidino-4-heteroarylthiazolen | |
| AT394192B (de) | Verfahren zur herstellung neuer substituierter aminoguanidin-derivate | |
| DE2847621A1 (de) | Phthalazin-derivate, verfahren zu ihrer herstellung und solche derivate enthaltende arzneimittel | |
| DD223452A5 (de) | Verfahren zur herstellung von piperidinochinazolinen | |
| DD265403A5 (de) | Verfahren zum herstellen herzstimulierender chinolene | |
| DE2313258A1 (de) | Verfahren zur herstellung von butyrophenonderivaten und ihren salzen neue butyrophenonderivate, ihre salze und diese verbindungen enthaltende arzneimittel | |
| WO1993012119A1 (de) | Thiadiazincarbonsäureamidderivate, verfahren zu ihrer herstellung und arzneimittel | |
| DE2723464C2 (de) | α-Trifluormethyl-2-benzylamino-oxazolin, Verfahren zu seiner Herstellung und es enthaltende pharmazeutische Zubereitungen | |
| DD210269A5 (de) | Verfahren zur herstellung von chinazolin-herzstimulantien | |
| DE3900028A1 (de) | Gegebenenfalls am phenylrest halogen- und/oder alkyl- und/oder alkoxy- oder methylendioxysubstituierte, 5,5-di-(methyl)-3-(phenylvinyl)-1-(substituiert amino-alkoxy-imino)-cyclohex-2-enderivate, verfahren zu ihrer herstellung sowie diese enthaltende arzneimittel | |
| DE3025238C2 (pt) | ||
| DE3439450A1 (de) | 1,2,4-triazolo-carbamate und ihre saeureadditionssalze, verfahren zu ihrer herstellung und arzneimittel | |
| DE4117750A1 (de) | Neue 2-amino-5-cyano-1,4-dihydropyridine, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln | |
| DE3324771A1 (de) | Heterocyclische verbindungen, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel | |
| CH645368A5 (de) | 2-hydroxy-5-(1-hydroxy-2-piperazinylethyl)benzoesaeure-derivate sowie verfahren zu deren herstellung. | |
| DE2425767A1 (de) | 3-alkyl-9-aminoalkyl-1,2,3,4-tetrahydrocarbazole und ihre verwendung in arzneimitteln |